EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children

Sheba Medical Center

Status and phase: Unknown; Phase 4

Conditions: Rhabdomyosarcoma

Treatments: Drug: doxorubicin, cytoxan

Study type: Interventional

Funder types: Other

Identifiers

NCT00339118

SHEBA-06-4013-IK-CTIL

Details and patient eligibility

About

The purpose of the study is achieve standardization treatment of low and intermediate risk rhabdomyosarcoma patients, with an attempt to improve treatment results in high and very high risk patients by the addition of doxorubicin as induction treatment and at the maintenance phase.

Sex: All

Ages: 6 months to 21 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• child
• non metastatic rhabdomyosarcoma
• adequate heart, kidney, liver function

Exclusion criteria

• age over 21 years, under 6 months
• metastatic disease
• heart, kidney, liver disease